Journals / Zeynep Kamil medical journal (Online) / 2021 / Cilt: 52 - Sayı: 4

Evaluation of the relationship between ocular surface symptoms and platelet-to-lymphocyte ratio in COVID-19 patients

Pages
188–192
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PLR may have a relevance to ocular surface symptoms in COVID-19 patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aims to evaluate ocular surface symptoms and their association with platelet-to-lymphocyte ratio (PLR) in patients who were clinically confirmed with coronavirus disease 2019 (COVID-19) using Ocular Surface Disease Index (OSDI) questionnaire.
📊
Key Findings & Data:Material and Methods: Thirty-five COVID-19 hospitalized patients were included in the study.
💡
Conclusion & Impact:PLR may have a relevance to ocular surface symptoms in COVID-19 patients.
🔬Design:Survey & Empirical Study
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: This study aims to evaluate ocular surface symptoms and their association with platelet-to-lymphocyte ratio (PLR) in patients who were clinically confirmed with coronavirus disease 2019 (COVID-19) using Ocular Surface Disease Index (OSDI) questionnaire. Material and Methods: Thirty-five COVID-19 hospitalized patients were included in the study. All patients had positive severe acute respiratory syndrome coronavirus 2 reverse-transcription polymerase chain reaction test results of nasopharyngeal and throat swab specimens as well as positive findings on computed tomography consistent with COVID-19. Ocular and medical histories were obtained from patients. Laboratory findings were noted. OSDI questionnaire was used to evaluate ocular surface symptoms. Results: There were 20 females (57.1%) and 15 males (42.9%) with a mean age 40.5 (95% CI: 35.8–45.2) years in the study. The mean OSDI scores were 12.6 (95% CI: 7.8–17.5). OSDI scores were significantly correlated with PLR (r=−0.516, p=0.028). Conclusion: Ocular surface problem is likely to occur in COVID-19 patients even in the absence of apparent ocular surface findings. PLR may have a relevance to ocular surface symptoms in COVID-19 patients.

🔖

Cite This Article

KALKIŞIM, A., ÇELİK, G., GÜNAY, B. Ö., ESENÜLKÜ, C. M. (2022). Evaluation of the relationship between ocular surface symptoms and platelet-to-lymphocyte ratio in COVID-19 patients. Zeynep Kamil medical journal (Online), Cilt: 52 - Sayı: 4, 188–192. https://ajindex.com/articles/426142

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel Coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol 2020;30(3):313–4
  2. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395(10223):470–3
  3. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on Coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res 2020;7(1):11
  4. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020;395(10224):e39
  5. Seah IY, Anderson DE, Kang AE, Wang L, Rao P, Young BE, et al. Assessing viral shedding and ınfectivity of tears in Coronavirus disease 2019 (COVID-19) patients. Ophthalmology 2020;127(7):977–9
  6. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patients with Coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020;138(5):575–8
  7. Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol 2020 26:10.1111/aos.14445. doi: 10.1111/aos.14445. [Epub ahead of print.] 8. Gambini G, Savastano MC, Savastano A, de Vico U, Crincoli E, Cozzupoli GM, et al. Ocular surface ımpairment after Coronavirus disease 2019: a cohort study. Cornea 2021;40(4):477–83
  8. Chan AS, Rout A. Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19. J Clin Med Res 2020;12(7):448–53
  9. Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with Coronavirus disease-19. J Med Virol 2020;92(9):1533–41
  10. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease ındex. Arch Ophthalmol 2000;118(5):615–21
  11. Ngo W, Situ P, Keir N, Korb D, Blackie C, Simpson T. Psychometric properties and validation of the standard patient evaluation of eye dryness questionnaire. Cornea 2013;32(9):1204–10
  12. Asiedu K, Kyei S, Mensah SN, Ocansey S, Abu LS, Kyere EA. Ocular surface disease index (OSDI) versus the standard patient evaluation of eye dryness (SPEED): A study of a nonclinical sample. Cornea 2016;35(2):175–80
  13. Caglar C, Senel E, Sabancilar E, Durmus M. Reduced ocular surface disease index (OSDI) scores in patients with i